| P50 | author | Cesar V. Borlongan | Q39649000 |
| | Daniel Watterson | Q43111946 |
| | Hiroto Ishikawa | Q59690395 |
| P2093 | author name string | Kazutaka Shinozuka | |
| | Naoki Tajiri | |
| | Yuji Kaneko | |
| | Loren E Glover | |
| | Nathan L Weinbren | |
| P2860 | cites work | Origins of circulating endothelial cells and endothelial outgrowth from blood | Q24599869 |
| | Targeting improves MSC treatment of inflammatory bowel disease | Q24601626 |
| | Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 |
| | An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injury | Q27642218 |
| | Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats | Q28209989 |
| | Cytokines and hematopoietic stem cell mobilization | Q28255913 |
| | A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow | Q28299027 |
| | Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 |
| | Death-associated protein kinase-mediated cell death modulated by interaction with DANGER | Q28509426 |
| | Niaspan increases angiogenesis and improves functional recovery after stroke | Q28574175 |
| | DAPK catalytic activity in the hippocampus increases during the recovery phase in an animal model of brain hypoxic-ischemic injury | Q28771384 |
| | Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 |
| | Very small embryonic-like stem cells are present in adult murine organs: ImageStream-based morphological analysis and distribution studies | Q30053358 |
| | Lack of telomerase activity in human mesenchymal stem cells | Q30164727 |
| | Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies | Q30195546 |
| | Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization | Q30876047 |
| | Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke | Q31096458 |
| | Pattern of cortex and white matter involvement in severe middle cerebral artery ischemia | Q31109683 |
| | Targeted insult to subsurface cortical blood vessels using ultrashort laser pulses: three models of stroke | Q33232366 |
| | Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma | Q33777681 |
| | Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 |
| | Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors | Q33887795 |
| | In vitro differentiation of endothelial cells from AC133-positive progenitor cells. | Q33901656 |
| | Mesenchymal stem cells as feeder cells for pancreatic islet transplants | Q34340690 |
| | How do stem cells find their way home? | Q34418463 |
| | Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model | Q34520694 |
| | The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells | Q34704081 |
| | Death-associated protein kinase as a potential therapeutic target | Q34837310 |
| | Treatment of neural injury with marrow stromal cells | Q35172499 |
| | The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders | Q35256491 |
| | Hemangioblasts, angioblasts, and adult endothelial cell progenitors | Q35618193 |
| | Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! | Q35792838 |
| | Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta | Q35796570 |
| | Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. | Q35840475 |
| | Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. | Q35985560 |
| | Endothelial progenitor cells | Q36014674 |
| | Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells | Q36132926 |
| | Are bone marrow stem cells plastic or heterogenous--that is the question | Q36135941 |
| | Stem-cell ecology and stem cells in motion | Q36528727 |
| | Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice | Q36545262 |
| | Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. | Q36808861 |
| | Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury | Q36909590 |
| | Endothelial progenitor cells and cerebrovascular diseases | Q36947568 |
| | Stem cells and neurological diseases. | Q37053159 |
| | Cell and gene therapy using mesenchymal stem cells (MSCs). | Q37076762 |
| | Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts | Q37152520 |
| | Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. | Q37178107 |
| | Cell-based therapy in ischemic stroke | Q37232009 |
| | Cell adhesion and signaling networks in brain neurovascular units | Q37251376 |
| | Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke | Q37354712 |
| | Who's in favor of translational cell therapy for stroke: STEPS forward please? | Q37656632 |
| | The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization | Q37829186 |
| | Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. | Q38347790 |
| | Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 |
| | The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2. | Q39564395 |
| | Transplantation of hNT neurons into the ischemic cortex: cell survival and effect on sensorimotor behavior. | Q40312503 |
| | Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke | Q40530106 |
| | The biology and application of human bone marrow stromal cell precursors | Q40951720 |
| | Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. | Q41486306 |
| | Endothelial cells in physiology and in the pathophysiology of vascular disorders | Q41757874 |
| | Transplantation of cultured human neuronal cells for patients with stroke | Q42492334 |
| | Adult bone marrow transplantation after stroke in adult rats | Q43569235 |
| | Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats | Q43727683 |
| | Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery | Q44115092 |
| | Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia | Q44127953 |
| | Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions | Q44495578 |
| | Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke | Q45042816 |
| | Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells | Q45148313 |
| | Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy | Q46549703 |
| | Antisense experiments demonstrate an exon 4 minus splice variant mRNA as the basis for expression of tNOX, a cancer-specific cell surface protein | Q46599530 |
| | Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke | Q46702521 |
| | Circulating CD34-positive cells provide an index of cerebrovascular function | Q47377874 |
| | Expression of brain natriuretic peptide by human bone marrow stromal cells | Q48105908 |
| | Persistent infarct hyperintensity on diffusion-weighted imaging late after stroke indicates heterogeneous, delayed, infarct evolution | Q48563530 |
| | Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. | Q51802891 |
| | Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. | Q52170394 |
| | Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. | Q52196589 |
| | Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. | Q54569449 |
| | Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. | Q54699022 |
| | Plasticity of marrow-derived stem cells | Q73740454 |
| | Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells | Q73763337 |
| | Using bone marrow stromal cells for treatment of stroke | Q74661667 |
| | Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 |
| | Endothelial progenitor cells during cerebrovascular disease | Q81089704 |
| | Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic | Q81230253 |
| | Autologous mesenchymal stem cell transplantation in stroke patients | Q81803888 |
| | Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines | Q82385171 |
| | Optimized flow cytometric analysis of endothelial progenitor cells in peripheral blood | Q82441157 |
| | From hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives | Q83825696 |
| P433 | issue | 1 | |
| P304 | page(s) | 90-98 | |
| P577 | publication date | 2011-11-18 | |
| P1433 | published in | Translational stroke research | Q26842494 |
| P1476 | title | A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells | |
| P478 | volume | 3 | |